Hina Khan recently opened up about the moment she learnt about her stage 3 breast cancer diagnosis and how she changed her mindset post that.

Chris Dutton has been a sport journalist since 2008, covering rugby union, rugby league, basketball, cricket and soccer. He ...

Companies like Amgen/Swedish Orphan Biovitrum, Access Pharmaceuticals, Chemo Mouthpiece/Aurora BioScience, and others are advancing Oral Mucositis ...

The St. Louis-born biopharmaceutical company has a new life and new focus, four months after its board sought to dissolve the ...

Viridans group streptococci (VGS) comprise five categories of microorganisms that are part of the human microbiome. They are usually found in oropharynx and in gastrointestinal and genitourinary ...

Durvalumab did not improve outcomes compared with cetuximab in patients with head and neck squamous cell carcinoma who are ...

Galera intends to leverage NCI grants, academic partnerships and the I-SPY 2 network for efficient and cost-effective clinical dataset expansion.

Brilacidin is under clinical development by Innovation Pharmaceuticals and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

Hina was diagnosed with stage 3 breast cancer in June 2024. As she undergoes treatment, the actress has openly shared the challenges she faces. She once disclosed experiencing mucositis, a side effect ...

Nibrozetone is under clinical development by EpicentRx and currently in Phase II for Oral Mucositis. According to GlobalData, Phase II drugs for Oral Mucositis does not have sufficient historical data ...

Oropharyngeal mucositis is an acute and distressing toxic effect of chemotherapy and head and neck irradiation. This oral sequela significantly impairs the daily functioning and quality of life of ...

Division of Regenerative Dental Medicine and Periodontology, University Clinics of Dental Medicine, Geneva, Switzerland Peri-implantitis is a progressive inflammatory disease affecting the tissues ...